Marjorie Egan

Marjorie Egan has extensive experience in regulatory affairs CMC, with a focus on the pharmaceutical industry. Marjorie is currently serving as the Executive Director of Regulatory Affairs CMC at Sage Therapeutics, a position they have held since April 2021. Prior to this, Marjorie worked at Ironwood Pharmaceuticals from August 2016 to April 2021, where they were the Senior Director of CMC Regulatory Affairs. Marjorie also worked at Infinity Pharmaceuticals as the Senior Director of Regulatory Affairs CMC from July 2013 to August 2016, and at AVEO Oncology as the Senior Director of Regulatory Affairs CMC from June 2012 to June 2013. Before that, they held roles at Vertex Pharmaceuticals as the Director of CMC Regulatory Affairs from May 2011 to June 2012, and as the Associate Director of CMC Regulatory Affairs from September 2007 to May 2011. Marjorie also worked at Idenix Pharmaceuticals as the Associate Director of CMC Regulatory Affairs from November 2004 to September 2007. Marjorie began their career at Merck & Co. Inc in December 1995, where they served as a Senior Regulatory Scientist until October 2004. Overall, Marjorie Egan has over 25 years of experience in regulatory affairs CMC in the pharmaceutical industry.

Marjorie Egan completed their education in the field of chemistry, specializing in organic chemistry. Marjorie received a Ph.D. from Boston University between 1987 and 1991. Prior to that, they obtained a B.A. from Connecticut College, graduating between 1983 and 1987. Marjorie'seducational journey began at Falmouth High School, where they completed their high school education from 1979 to 1983.